WARNING

Necitumumab injection is a medication used in the treatment of certain types of advanced non-small cell lung cancer (NSCLC). While it can be effective in some cases, like any medical treatment, it comes with potential risks and side effects. Some of the risks associated with taking Necitumumab injection include:

• Infusion reactions: Patients may experience allergic or hypersensitivity reactions during or shortly after receiving the injection. These reactions can include fever, chills, rash, difficulty breathing, and low blood pressure.
• Skin toxicity: Necitumumab may cause skin reactions, such as rash, acne-like eruptions, or dry skin. In some cases, these skin issues can be severe.
• Hypomagnesemia: This is a condition where the blood magnesium levels become low. It can lead to symptoms like muscle weakness, seizures, irregular heartbeat, and fatigue.
• Venous and arterial thromboembolic events: Necitumumab use has been associated with an increased risk of blood clots forming in veins (venous thrombosis) or arteries (arterial thrombosis), which can be serious and even life-threatening.
• Interstitial lung disease: Some patients may experience inflammation and scarring of lung tissue, leading to breathing difficulties and lung-related symptoms.
• Cardiopulmonary arrest: Rare cases of cardiac arrest have been reported in patients receiving Necitumumab.
• Other side effects: Patients may experience other common side effects such as fatigue, nausea, diarrhea, and decreased appetite.

It’s essential for patients receiving Necitumumab injection to be closely monitored by their healthcare providers to promptly identify and manage any potential side effects or adverse reactions. Before starting this treatment, patients should discuss all potential risks and benefits with their oncologist to make informed decisions about their cancer treatment plan.

Why is this medication prescribed?

Necitumumab injection is prescribed for the treatment of certain types of advanced non-small cell lung cancer (NSCLC). It is specifically used in combination with other chemotherapy medications, such as cisplatin and gemcitabine, for patients with metastatic squamous NSCLC who have not received prior systemic therapy for their advanced disease.

The medication works by targeting and blocking a protein called epidermal growth factor receptor (EGFR) on cancer cells. By doing so, it helps inhibit the growth and spread of cancer cells, potentially slowing down the progression of the disease.

How should this medicine be used?

Necitumumab is administered as an intravenous (IV) infusion by a healthcare professional in a medical setting, such as a hospital or clinic. The dosage and frequency of administration are determined by the oncologist based on the patient’s specific condition and overall health.

The injection is typically given on a once-a-week schedule, with cycles of three weeks on treatment followed by one week off. This is known as a 3-week treatment cycle.

It’s crucial for patients to follow their oncologist’s instructions regarding the treatment schedule and to attend all scheduled appointments for the IV infusions. Additionally, patients should be aware of the potential side effects and inform their healthcare provider promptly if they experience any adverse reactions during or after the treatment.

As with any cancer treatment, the decision to use Necitumumab injection should be made in consultation with the oncologist, taking into account the individual patient’s medical history, the stage and characteristics of the cancer, and potential interactions with other medications or treatments. The aim is to achieve the best possible outcomes while carefully managing any associated risks or side effects.

Other uses for this medicine

Necitumumab injection is primarily used for the treatment of advanced squamous non-small cell lung cancer (NSCLC) in combination with other chemotherapy agents, specifically cisplatin and gemcitabine. It has not been approved for use in other medical conditions or cancer types.

What special precautions should I follow?

Regarding special precautions, there are several important considerations for patients receiving Necitumumab injection:

• Allergic reactions: Patients should be monitored closely for any signs of allergic reactions during and after the infusion. If symptoms like difficulty breathing, hives, or swelling occur, medical attention should be sought immediately.
• Magnesium levels: Hypomagnesemia (low blood magnesium levels) is a potential side effect of Necitumumab. Healthcare providers may monitor magnesium levels regularly and provide appropriate supplementation if needed.
• Blood clotting: Necitumumab use has been associated with an increased risk of blood clot formation in veins and arteries. Patients with a history of blood clotting disorders or those at risk should be carefully evaluated before starting treatment.
• Skin toxicity: Skin reactions, such as rash and acne-like eruptions, are possible with Necitumumab. Patients should inform their healthcare provider if they experience any skin changes or discomfort.
• Interstitial lung disease: This condition, characterized by lung inflammation and scarring, has been reported in some patients receiving Necitumumab. Patients should report any new or worsening respiratory symptoms to their healthcare provider promptly.
• Pregnancy and breastfeeding: Necitumumab can cause harm to an unborn baby, so it should not be used during pregnancy unless absolutely necessary. It is also not recommended during breastfeeding, as it may pass into breast milk and harm the nursing infant.
• Informing healthcare providers: Patients should inform their healthcare providers about all medical conditions, medications, and supplements they are taking before starting Necitumumab treatment to avoid potential interactions or contraindications.
• Regular monitoring: Patients undergoing Necitumumab treatment will require regular monitoring of their overall health, blood counts, and organ function to assess treatment response and manage any potential side effects.

It is essential for patients to have open and thorough discussions with their healthcare providers about the potential risks and benefits of Necitumumab treatment. Compliance with medical advice and close monitoring can help ensure the safest and most effective use of this medication.

What special dietary instructions should I follow?

There might not be specific dietary instructions associated with Necitumumab. However, during cancer treatment, it’s essential to maintain a balanced and nutritious diet to support overall health and well-being. Your healthcare provider or a registered dietitian can provide personalized dietary recommendations based on your health status and any potential side effects of the medication.

What should I do if I forget a dose?

If you forget a scheduled dose of Necitumumab, contact your healthcare provider immediately for further guidance. They will advise you on the appropriate action to take. It’s important not to administer an extra dose without consulting a healthcare professional.

What side effects can this medication cause?

Necitumumab injection, like any medication, can cause side effects. Not everyone will experience these side effects, and their severity can vary from person to person. It’s important to remember that the benefits of the treatment are weighed against the potential side effects. Common side effects of Necitumumab injection may include:

• Infusion reactions: Allergic or hypersensitivity reactions during or shortly after receiving the injection. Symptoms may include fever, chills, rash, difficulty breathing, and low blood pressure.
• Skin toxicity: Skin reactions such as rash, acne-like eruptions, or dry skin.
• Magnesium deficiency (hypomagnesemia): Low levels of magnesium in the blood, which can lead to symptoms like muscle weakness, seizures, irregular heartbeat, and fatigue.
• Blood clotting issues: Necitumumab use has been associated with an increased risk of blood clot formation in veins (venous thrombosis) and arteries (arterial thrombosis).
• Interstitial lung disease: A condition characterized by inflammation and scarring of lung tissue, which can cause breathing difficulties and other lung-related symptoms.
• Cardiopulmonary arrest: Rare cases of cardiac arrest have been reported in patients receiving Necitumumab.
• Other common side effects: Fatigue, nausea, diarrhea, decreased appetite, and general weakness.

It’s crucial to discuss potential side effects with your healthcare provider before starting Necitumumab treatment. They will closely monitor your health and adjust the treatment plan as needed to manage any side effects that may arise. If you experience any unexpected or severe side effects during treatment, it’s important to inform your healthcare provider immediately, as they can provide appropriate support and interventions.

Keep in mind that this list of side effects is not exhaustive, and there may be other possible adverse reactions associated with the medication. Each individual’s response to the treatment is unique, and your healthcare provider will tailor the treatment plan to suit your specific needs and circumstances

What should I know about storage and disposal of this medication?

Storage and Disposal of Necitumumab Injection:

• Storage: Necitumumab injection should be stored in its original packaging in the refrigerator at 2°C to 8°C (36°F to 46°F). Protect the vials from light by keeping them in the outer carton until ready for use. Do not freeze the medication, and do not use it beyond the expiration date mentioned on the label.
• Disposal: Properly dispose of any unused or expired Necitumumab injection as instructed by your healthcare provider or local guidelines. It is essential to follow safe disposal practices for medications to prevent accidental exposure to others and minimize environmental impact. You can consult your healthcare provider, pharmacist, or local waste management authorities for guidance on the proper disposal method.

In case of emergency/overdose

In the event of an emergency or accidental overdose, seek immediate medical attention or contact your local poison control center. It is essential to provide all relevant information about the medication and its dosage to the healthcare professionals to ensure appropriate management of the situation.

What other information should I know?

• Medication Interactions: Before starting Necitumumab treatment, inform your healthcare provider about all other medications, supplements, and herbal products you are taking. Some drugs may interact with Necitumumab, affecting its effectiveness or increasing the risk of side effects.
• Pregnancy and Breastfeeding: Inform your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding. Necitumumab may cause harm to the fetus, so it is essential to discuss the risks and benefits with your healthcare provider.
• Regular Follow-up: Attend all scheduled appointments with your healthcare provider for follow-up assessments and monitoring during the course of treatment.
• Inform Healthcare Providers: Inform all healthcare providers involved in your care that you are receiving Necitumumab injection. This includes dentists and other specialists to ensure coordinated care and prevent potential interactions with other treatments or procedures.
• Compliance: Follow your healthcare provider’s instructions carefully regarding the dosage schedule and any additional precautions to maximize the benefits of the medication and minimize the risks.

Always keep a list of all the medications you are taking, including Necitumumab injection, and share it with your healthcare providers during each visit. Open communication and cooperation with your healthcare team are essential for ensuring the safest and most effective management of your cancer treatment. If you have any concerns or questions about your treatment or medication, do not hesitate to discuss them with your healthcare provider.